Johnson & Johnson secured FDA approval for its Ottava robotic surgical system. This authorization allows entry into the growing soft-tissue robotic surgery market. The system is approved for several general surgery procedures in the upper abdomen. Ottava features a smaller operating room footprint compared to existing systems. The company aims to challenge Intuitive Surgical’s dominance in this field.
Related Posts
Why Afghanistan captain Shahidi was punished by ICC after the third ODI vs India
Afghanistan captain Hashmatullah Shahidi received an official reprimand and a demerit point from the ICC for damaging the pitch during…
After Skyroot, more private firms aim to take commercial dreams to sky
India’s private space sector is accelerating after a historic rocket launch. Companies are now preparing for commercial missions and reusable…
8 years apart, spot the difference: Gurgaon’s annual infrastructure betrayal
Gurgaon experienced significant disruption from recent monsoon rains. Major roads flooded, causing extensive traffic jams and stranding many commuters. Despite…